Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapyINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22024-04-010PRE
In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release FormulationsPHARMACEUTICSIF5.52023-09-064OAAI
Evaluating the pharmacokinetics of intrapulmonary administered ciprofloxacin solution for respiratory infections using in vivo and in silico PBPK rat model studiesCHINESE CHEMICAL LETTERSIF8.92023-01-015PRE
Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infectionsINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22022-03-0118PRE
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicinesACTA PHARMACEUTICA SINICA BIF14.62021-08-0181OAAI
In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug吸入药物产品开发中的体外-体内-计算机模拟方法: 以布地奈德为模型药物的纳米晶体制剂ASIAN JOURNAL OF PHARMACEUTICAL SCIENCESIF11.92021-05-019OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向